| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.03 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.03 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.32 | 0.03 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.12 | 0.04 |